Medicare Enrolled

Dr. Oliver Ong, M.D.

Endocrinology · Glendale, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
801 S CHEVY CHASE DR, Glendale, CA 91205
8182652242
In practice since 2006 (19 years)
NPI: 1811951734 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ong from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ong? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ong

Dr. Oliver Ong is an endocrinology specialist in Glendale, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ong performed 1,642 Medicare services across 836 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ong received a total of $13,953 from 57 pharmaceutical and/or device companies across 761 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ong is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 32% volume in CA $13,953 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,642
Medicare services
Top 32% in CA for endocrinology
836
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~86 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
686 $105 $280
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
674 $42 $79
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
106 $111 $278
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
81 $138 $360
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
33 $51 $198
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
24 $68 $147
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
19 $13 $40
Initial hospital admission, low complexity
Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter.
19 $60 $206
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,953
Total received (2018-2024)
Avg $1,993/year across 7 years
Top 16% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
761
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,953 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,398
2023
$2,391
2022
$2,005
2021
$1,564
2020
$1,299
2019
$2,128
2018
$2,169

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$350
Lilly USA, LLC
$294
Amgen Inc.
$275
Boehringer Ingelheim Pharmaceuticals, Inc.
$247
Dexcom, Inc.
$196
Radius Health, Inc.
$140
Lexicon Pharmaceuticals, Inc.
$109
Abbott Laboratories
$87
Verity Pharmaceuticals Inc.
$82
ABBVIE INC.
$73
Xeris Pharmaceuticals, Inc.
$68
SANOFI-AVENTIS U.S. LLC
$60
Amphastar Pharmaceuticals, Inc.
$53
Medtronic, Inc.
$47
Antares Pharma, Inc.
$45
Novartis Pharmaceuticals Corporation
$40
Corcept Therapeutics
$37
Bayer Healthcare Pharmaceuticals Inc.
$35
Averitas Pharma Inc.
$32
Insulet Corporation
$31
BETA BIONICS, INC.
$28
Ascensia Diabetes Care Us Inc.
$27
AstraZeneca Pharmaceuticals LP
$24
Ascendis Pharma Inc
$17
Top 3 companies account for 38.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$2,675
Lilly USA, LLC
$1,434
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,294
SANOFI-AVENTIS U.S. LLC
$884
Amgen Inc.
$880
AstraZeneca Pharmaceuticals LP
$790
Abbott Laboratories
$529
Dexcom, Inc.
$432
Merck Sharp & Dohme Corporation
$429
Radius Health, Inc.
$342
Bayer Healthcare Pharmaceuticals Inc.
$297
Xeris Pharmaceuticals, Inc.
$276
Medtronic, Inc.
$265
ABBVIE INC.
$239
Horizon Therapeutics plc
$219
Mannkind Corporation
$210
Medtronic MiniMed, Inc.
$209
Insulet Corporation
$202
Valeritas, Inc.
$191
Corcept Therapeutics
$163
MannKind Corporation
$141
Becton, Dickinson and Company
$137
Lexicon Pharmaceuticals, Inc.
$109
IBSA Pharma Inc.
$109
Amarin Pharma Inc.
$92
Antares Pharma, Inc.
$89
CeQur Corporation
$86
Bayer HealthCare Pharmaceuticals Inc.
$84
Janssen Pharmaceuticals, Inc
$84
Verity Pharmaceuticals Inc.
$82
Shire North American Group Inc
$78
AbbVie Inc.
$71
AbbVie, Inc.
$63
Regeneron Healthcare Solutions, Inc.
$60
Amryt Pharma Holdings Ltd
$56
Amphastar Pharmaceuticals, Inc.
$53
Nestle HealthCare Nutrition Inc.
$47
Embecta Corp.
$47
Ascensia Diabetes Care Us Inc.
$44
Merck Sharp & Dohme LLC
$43
PFIZER INC.
$43
Ultragenyx Pharmaceutical Inc.
$41
Novartis Pharmaceuticals Corporation
$40
VistaPharm, Inc.
$40
Averitas Pharma Inc.
$32
BETA BIONICS, INC.
$28
Acerus Pharmaceuticals Corporation
$26
Supernus Pharmaceuticals, Inc.
$23
DEXCOM, INC.
$22
RECORDATI_RARE_DISEASES_INC.
$19
EUSA Pharma (US) LLC
$19
Vertiflex, Inc.
$18
Ascendis Pharma Inc
$17
Teva Pharmaceuticals USA, Inc.
$14
GlaxoSmithKline, LLC.
$12
Tandem Diabetes Care, Inc.
$12
Allergan, Inc.
$12
Top 3 companies account for 38.7% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AJOVY · Androgel · BAQSIMI · BD NANO · BD Nano 2nd Gen Pen Needle · BD Ultra-Fine · BYDUREON · CRYSVITA · CeQur Simplicity · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMALOG · HUMULIN · INVOKANA · ISTURISA · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LANTUS · LEQVIO · LOKELMA · Levemir · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · Minimed 770G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NOCDURNA · Natesto · OTREXUP · Omnipod · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PROCLAIM · Prolia · QUTENZA · RECORLEV · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLATRO · SYNTHROID · Superion ISS · Sylvant · Synthroid · TEPEZZA · TLANDO · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · TZIELD · Thyquidity · Tirosint · Tlando · Tresiba · Tymlos · UBRELVY · V-GO · VERQUVO · Vascepa · Victoza · Wegovy · XARELTO · XYOSTED · ZENPEP · ZEPBOUND · iLet Bionic Pancreas · t-slim insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Glendale?
Compare endocrinologists in the Glendale area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
268
Per 100K population
2.7
County median income
$87,760
Nearest hospital
GLENDALE MEM HOSPITAL & HLTH CENTER
0.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ong is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 16% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ong experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Ong performed 686 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ong receive payments from pharmaceutical companies?
Yes. Dr. Ong received a total of $13,953 from 57 companies across 761 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ong's costs compare to other endocrinologists in Glendale?
Dr. Ong's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ong) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →